At-home testing can offer a more robust picture of health, according to experts.
The scale doesn’t lie—but it doesn’t tell the whole story.
You might be eating better, exercising more, and still seeing the same number each morning. It’s frustrating, discouraging, and, as it turns out, possibly misleading.
For decades, weight has been treated as a primary marker of health. But a number on the scale says little about inflammation, cardiovascular risk, or metabolic dysfunction—factors that often shift before any visible weight loss appears.
That’s why more people are turning to at-home biomarker testing—health tracking that looks beneath the surface, revealing internal changes long before they’re visible in the mirror or on the scale.
Colin Godby, an engineer and father of two, tested his blood out of curiosity, not concern. What he found was unexpected—and alarming.
The at-home test revealed that Godby had hereditary hemochromatosis, a genetic condition that causes iron to accumulate in the body. Left untreated, it can lead to liver disease, heart problems, and other complications. It was a diagnosis standard labs hadn’t caught—and likely wouldn’t have.
“I’d been chalking up fatigue and joint pain to getting older,” he said. “But this gave me answers. Real ones.”
What stood out to Godby wasn’t just the result—it was the realization that he might never have discovered the issue through routine care. He hadn’t planned to see a doctor, and even if he had, a ferritin test likely wouldn’t have been part of a standard workup.
“I realized how blind I was to the nuance of my health,” said Godby. “And how likely it would be for many other people to also have potential issues they might not know about.”
From COVID-19 Swabs to Full Panels
During the pandemic, millions swabbed their noses at home and waited for COVID-19 test results—an experience that introduced many to the idea of testing health at home.
“COVID normalized the idea that you could test yourself and act on the results,” said Jordan Moradian, a product and growth manager at SiPhox Health, a direct-to-consumer testing company, in an interview with The Epoch Times.
Even before the pandemic, health tracking was gaining traction among wellness enthusiasts. COVID-19 accelerated the trend, Moradian said, fueled by renewed interest in immunity, more time at home, and popular science voices like Andrew Huberman.
Today, companies like SiPhox, Everlywell, LetsGetChecked, and QuestHealth offer clinical-grade diagnostics at home. Tests typically use finger-prick or saliva samples to measure everything from blood sugar and inflammation to hormones and cholesterol—and deliver results in days.
The global home testing market, valued at more than $10.5 billion in 2024, is projected to nearly double by 2030, according to Grand View Research. The growth reflects a shift toward preventive, patient-led care—emphasizing early detection, frequent monitoring, and personal agency.
By Sheramy Tsai
